Drug-related pneumonitis induced by osimertinib as first-line treatment for EGFR-positive non-small cell lung cancer: a real-world setting

Drug-related pneumonitis (DRP) is a potentially lethal complication of osimertinib treatment, but reliable real-world data currently are lacking.

Provider:American College of Chest Physicians
Activity Link: https://www.chestnet.org/journal/
Start Date: 2022-11-04 05:00:00
End Date: 2022-11-04 05:00:00
Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
Commercial Support: No
Activity Type: Journal-based CE
CME Finder Type: Other
Fee to Participate: No, it's free
Measured Outcome: Learner Competence
Provider Ship: Directly Provided
Registration: Open to all
Specialty: Pulmonary Disease

Subscribe

0 Comments

Oldest

Newest Most Voted

Inline Feedbacks

View all comments

0

Would love your thoughts, please comment.x

()